Bausch & Lomb Incorporated, a leading global eye health company, is headquartered in the United States and operates extensively across North America, Europe, and Asia. Founded in 1853, Bausch & Lomb has established itself as a pioneer in the ophthalmic industry, achieving significant milestones such as the development of the first soft contact lens. The company specialises in a diverse range of products, including contact lenses, lens care solutions, and ophthalmic surgical devices. Bausch & Lomb's commitment to innovation and quality sets its offerings apart, particularly in the realm of advanced contact lens technology and eye care solutions. With a strong market position, the company is recognised for its dedication to improving vision and eye health, making it a trusted name among consumers and healthcare professionals alike.
How does Bausch & Lomb Incorporated's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Bausch & Lomb Incorporated's score of 40 is higher than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Bausch & Lomb Incorporated, headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Bausch Health Companies Inc., which may influence its climate commitments and emissions reporting. As of now, Bausch & Lomb has not publicly disclosed any specific reduction targets or initiatives related to carbon emissions. The absence of documented reduction targets suggests that the company may be in the early stages of developing a comprehensive climate strategy. Bausch & Lomb's climate commitments and performance may be informed by the broader initiatives of its parent company, Bausch Health Companies Inc., which has established various sustainability goals. However, specific details regarding these initiatives or their impact on Bausch & Lomb's operations are not provided. In summary, while Bausch & Lomb is part of a larger corporate family that may have climate commitments, there is currently no available data on its carbon emissions or specific reduction targets.
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 46,686,000 | 00,000,000 |
| Scope 2 | 50,513,000 | 00,000,000 |
| Scope 3 | 19,260,000 | 00,000,000 |
Bausch & Lomb Incorporated's Scope 3 emissions, which increased by 41% last year and increased by approximately 41% since 2022, demonstrating supply chain emissions tracking. Their carbon footprint includes suppliers and value chain emissions, with Scope 3 emissions accounting for 21% of total emissions under the GHG Protocol, with "Waste Generated in Operations" representing nearly all of their reported Scope 3 footprint.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Bausch & Lomb Incorporated has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.